Company: Aromyx Corp.
Job title: CEO
Dr. Silverman has 20 years of experience in new biotechnology research, development and commercialization. Before joining Aromyx he was Founder and Chief Technology Officer of Calysta, Inc., where he led development of technology converting methane gas to protein using bacteria. Previously, he was Vice President of Drug Development at Amunix, Inc. Dr. Silverman co-founded Versartis, Inc. in 2008 and participated in the founding and financing of four startup biotechnology companies (Avidia, Diartis, Siluria and Calysta). He has held positions at two public biotechnology companies, Maxygen, Inc. and Amgen, Inc.
Dr. Silverman earned his B.Sc. in Molecular Biology from UC San Diego and his Ph.D. in Biochemistry from Stanford University.
Smart Reformulation Technology: Using Data Science in Rapid Reformulation Efforts 12:17 pm
day: Day One